Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
about
Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.Caffeic acid phenethyl ester and therapeutic potentialsMetabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.
P2860
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
@en
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester
@nl
type
label
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
@en
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester
@nl
prefLabel
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
@en
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester
@nl
P2093
P2860
P356
P1433
P1476
Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).
@en
P2093
Hong Zhang
Liping Zhang
Renwei Zhang
Shangke Chen
Xiaopeng Hu
Xuehua Zheng
Yining Zhao
Yunyun Chen
P2860
P304
P356
10.1002/CMDC.201300455
P577
2014-01-16T00:00:00Z